| Offering Information |
| Expected Date | - |
| Proposed Exchange/Ticker |
Nasdaq: ARXT |
| Security Type |
Common Stock |
| Lead Underwriter |
Merrill Lynch Morgan Stanley |
| Days In Registration |
117 |
| Date Filed |
25-Mar-2005 |
| Form Filed | S-1 |
Fundamentals
(Year Ending December 2007) |
| Industry |
Manufacturing |
| Business Description |
Adams Respiratory Therapeutics Inc, located in Chester, New Jersey, manufactures pharmaceuticals intended for final consumption, focused on prescription pharmaceuticals for the treatment of respiratory disorders. Its product line includes Mucinex, Mucinex DM, Mucinex D; Maximum Strength Mucinex, Mucinex DM, and Mucinex D; the Delsym line of products; Mucinex Moisture Smart and Mucinex Full Force nasal sprays; and the Mucinex for Children line of products. |
| Revenue |
- |
| Net Income |
- |
| Shares Outstanding (post-offering) |
31.97M |
| Contact |
- |
| Number of Employees |
- |
|
| Original Filing Information |
| US |
| Shares Filed |
7.08M |
| Secondary Shares Filed | 1.75M |
| · As a Percent |
24.7 |
| Primary Shares Filed |
5.33M |
| · As a Percent |
75.3 |
| Overallotment Shares Filed |
1192.5K |
| File Amount |
$106.19M |
| File Price Range |
$16.00 - $14.00 |
| File Mid Price |
$15.00 |
Current Filing Information
(Amended 19-Jul-2005) |
|
US |
|
Shares Filed |
7.08M |
| Secondary Shares Filed |
1.75M |
| · As a Percent |
24.7 |
| Primary Shares Filed |
5.33M |
| · As a Percent |
75.3 |
| Overallotment Shares Filed |
- |
| File Amount |
$106.19M |
| · % Change from Original |
0.0 |
| File Price Range |
$16.00 - $14.00 |
| File Mid Price |
$15.00 |
|
